Jump to Contents
noul
  • Company
    • About
    • History
    • Leadership
    • Sustainability
  • miLab Platform
    • Concept
    • Core Technology
    • Related Products
  • Product
    • Malaria
    • Blood Count & Morphology
    • Cervical Cancer
  • Media
    • News
    • Blog
  • Career
    • Working at Noul
    • Open Positions
  • Investors
    • Why Invest
    • Stock info.
Contact
  • EN|
  • KR
Contact
Blog

Noul’s story on sustainability, cultures
and impact business

Newest Oldest
  • Comprehensive Guide to Instructions for Use NOUL’s miLab™ – MAL for Malaria Diagnosis

    2025.01.28

  • UNITAID, Precancerous lesion, Cervical intraepithelial neoplasia, Cytology Innovating Global Health miLab™ Featured in UNITAID Reports

    2025.01.24

  • cervical health awareness month, what happens if you never get a pap smear, pre-cervical cancer, how to prevent cervical cancer Cervical Health Awareness Month – Preventing Cervical Cancer with Early Detection and Pap Smears

    2025.01.21

  • Limbach, medical diagnostic labs, supply agreement, diagnostic laboratory NOUL Signs Major Supply Agreement with Limbach Gruppe SE to Enhance Diagnostic Services

    2025.01.17

  • CES 2025, ESG strategy, sustainable management, digitalization and technology CES 2025 Highlights: NOUL’s Biotechnological Innovations and ESG Strategies in Diagnostics

    2025.01.14

  • Malaria diagnosis, Microscopic examination, Rapid diagnostic test, Dipstick, Molecular diagnosis 3 Comprehensive Malaria Diagnostic Solutions: Microscopic Examination, RDTs, and PCR for Accurate Detection

    2025.01.10

  • Immunochemistry staining, Immunostaining, biopolymers, hydrogel NGSI Technology: Revolutionizing Immunohistochemistry Staining with Hydrogel-Based Innovation

    2025.01.07

  • LSIL, HSIL, NILM, ASC-H, Squamous Cell Carcinoma, Atypical Squamous Cells with Unparalleled precision 6 Cervical Health Indicators Analyzed by miLab™ CER – HSIL, LSIL, NILM, ASC-H, ASC-US, and SCC

    2025.01.03

  • automated diagnostic, diagnostic solution, AI and digitalization, biotechnology innovations Revolution of Automated Diagnostics Solution: NOUL’s miLab™ BCM Expands to Europe

    2024.12.31

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Company
    • About
    • History
    • Leadership
    • Sustainability
  • miLab Platform
    • Concept
    • Core Technology
    • Related Products
  • Product
    • Malaria
    • Blood Count & Morphology
    • Cervical Cancer
  • Media
    • News
    • Blog
  • Career
    • Working at Noul
    • Open Positions
  • Investors
    • Why Invest
    • Stock info.
  • Product Inquiry|
  • Disclaimer|
  • Privacy Policy
noul
B-6F/10F, 338, Gwanggyojungang-ro, Suji-gu, Yongin-si,
Gyeonggi-do, 16942, Republic of Korea

Copyright © Noul Co., Ltd. All Rights Reserved.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Cookie Policy

More information about our Cookie Policy